HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruchi Saxena Selected Research

Hyperopia (Hypermetropia)

6/2021Implantation of an iris-fixated phakic intraocular lens for the correction of hyperopia: 15-year follow-up.
7/2003Three-year follow-up of the Artisan phakic intraocular lens for hypermetropia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruchi Saxena Research Topics

Disease

5Neoplasms (Cancer)
01/2021 - 06/2013
5Breast Neoplasms (Breast Cancer)
01/2016 - 01/2012
2Hyperopia (Hypermetropia)
06/2021 - 07/2003
2Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 02/2019
2Pain (Aches)
04/2020 - 08/2016
1Overweight
11/2021
1Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
11/2021
1Gestational Diabetes (Gestational Diabetes Mellitus)
11/2021
1Rupture
11/2021
1Pre-Eclampsia (Preeclampsia)
11/2021
1Postpartum Hemorrhage
11/2021
1Starvation
01/2021
1Kidney Neoplasms (Kidney Cancer)
01/2020
1Melanoma (Melanoma, Malignant)
01/2020
1Osteoporosis
01/2017
1Postoperative Pain
08/2016
1Malocclusion (Crossbite)
01/2014
1Refractive Errors (Refractive Error)
10/2013
1Oculocutaneous Albinism (Albinism, Yellow Mutant)
10/2013
1Adenocarcinoma
06/2013
1Endometrial Neoplasms (Endometrial Cancer)
06/2013
1Carcinogenesis
06/2013
1Hyperplasia
10/2011
1Astigmatism
07/2006
1Myopia
04/2003
1Amblyopia (Lazy Eye)
04/2003

Drug/Important Bio-Agent (IBA)

3BenzopyransIBA
01/2017 - 01/2013
3PyransIBA
11/2013 - 10/2011
3Estrogen ReceptorsIBA
11/2013 - 01/2013
2CDRI 85-287 (PEPP)IBA
11/2013 - 01/2013
2ErbB Receptors (EGF Receptor)IBA
01/2013 - 01/2012
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
1angiotensin I (1-7)IBA
01/2021
1Diclofenac (SR 38)FDA LinkGeneric
04/2020
1Fentanyl (Sublimaze)FDA LinkGeneric
04/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Axitinib (AG 013736)IBA
01/2020
1Chemokine ReceptorsIBA
01/2020
1PerforinIBA
01/2020
1Cathepsin BIBA
02/2019
1PterocarpansIBA
01/2017
1Opioid Analgesics (Opioids)IBA
08/2016
1OxindolesIBA
01/2016
1indolineIBA
01/2016
1SpirooxindolesIBA
02/2015
1spirooxindoleIBA
02/2015
1Selective Estrogen Receptor Modulators (SERM)IBA
11/2013
1Estrogens (Estrogen)FDA Link
11/2013
1Progesterone Receptors (Progesterone Receptor)IBA
06/2013
1TeaIBA
06/2013
1PolyphenolsIBA
06/2013
1Proliferating Cell Nuclear Antigen (PCNA)IBA
06/2013
1Cyclin D1IBA
06/2013
1p38 Mitogen-Activated Protein KinasesIBA
06/2013
1Glutathione (Reduced Glutathione)IBA
06/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2013
1Epidermal Growth Factor (EGF)IBA
01/2013
1Trastuzumab (Herceptin)FDA Link
01/2012
1Estradiol (Delestrogen)FDA LinkGeneric
10/2011
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
07/2006

Therapy/Procedure

5Phakic Intraocular Lenses
06/2021 - 04/2003
5Therapeutics
01/2021 - 04/2003
2Laparoscopic Cholecystectomy
04/2020 - 08/2016
1Induced Labor
11/2021
1Medical Day Care (Partial Hospitalization)
08/2016
1Analgesia
08/2016
1Orthognathic Surgery
01/2014
1Drug Therapy (Chemotherapy)
01/2012